Pricing Log in Create free account
Saturday 17 October 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025. In the quarter to June 2026, revenue grew 1.71%, EPS fell 4.35%, free cash flow fell 95.6% and total debt fell 2.58%, each against the same quarter a year earlier.

19.67 0.22 +1.13%
Market cap
$61.9B
P/E
29.6×
Fwd P/E
—
Dividend yield
1.57%
F-score
4/9
Altman Z
1.03
Beneish M
−2.65
Dividend safety
25/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Takeda Pharmaceutical Co. (TAK) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Takeda Pharmaceutical Co. (TAK) trades at a P/E ratio of 29.6×. Over the past ten years it has ranged from 0.0× (June 2017) to 150× (May 2020); the current reading is higher than 61% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 19.2× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 27.5× (44.82%)
FY2025 49.7× 16.06%
FY2024 42.9× 100.28%
FY2023 21.4× (1.84%)
FY2022 21.8× 36.12%
FY2021 16.0× (86.25%)
FY2020 117× 1,094.01%
FY2019 9.8× (85.20%)
FY2018 65.9× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 24.1× 5.25%
Jun 2025 22.9× (47.31%)
Jun 2024 43.5× 1.46%
Mar 2024 42.9× 23.85%
25 more quarters

Against its own ten years

Low 0.0× High 150×
Ten-year median 23.2×
Current reading's percentile 53

P/E ratio against peers

Company P/E ratio
VTRS Viatris Inc. compare n/m
ELAN Elanco Animal Health Incorporated compare n/m
ZTS Zoetis Inc. compare 13.0×
UTHR United Therapeutics Corporation compare 17.6×
NBIX Neurocrine Biosciences, Inc. compare 19.2×
HLN Haleon PLC Sponsored ADR compare 22.6×
TAK Takeda Pharmaceutical Co. 29.6×
RDY Dr. Reddy's Laboratories Ltd compare 32.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 65.9×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on TAK